Kotamarti, Srinath, Zoe Michael, David Silver, Ervin Teper, Alireza Aminsharifi, Thomas J. Polascik, and Ariel Schulman. “Device-related complications during renal cryoablation: insights from the Manufacturer and User Facility Device Experience (MAUDE) database.” Urol Oncol 40, no. 5 (May 2022): 199.e9-199.e14. https://doi.org/10.1016/j.urolonc.2022.03.002.
Owens, Jake L., Elena Beketova, Sheng Liu, Qi Shen, Jogendra Singh Pawar, Andrew M. Asberry, Jie Yang, et al. “Targeting Protein Arginine Methyltransferase 5 Suppresses Radiation-induced Neuroendocrine Differentiation and Sensitizes Prostate Cancer Cells to Radiation.” Mol Cancer Ther 21, no. 3 (March 1, 2022): 448–59. https://doi.org/10.1158/1535-7163.MCT-21-0103.
Bakavicius, Arnas, Giancarlo Marra, Petr Macek, Cary Robertson, Andre L. Abreu, Arvin K. George, Bernard Malavaud, et al. “Available evidence on HIFU for focal treatment of prostate cancer: a systematic review.” Int Braz J Urol 48, no. 2 (March 2022): 263–74. https://doi.org/10.1590/S1677-5538.IBJU.2021.0091.
Orabi, Hazem, Lauren Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, et al. “Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry.” Eur Urol Open Sci 37 (March 2022): 106–12. https://doi.org/10.1016/j.euros.2022.01.003.
Berger, Miles, Jeffrey N. Browndyke, Mary Cooter Wright, Chloe Nobuhara, Melody Reese, Leah Acker, W Michael Bullock, et al. “Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers.” Ann Clin Transl Neurol 9, no. 2 (February 2022): 155–70. https://doi.org/10.1002/acn3.51499.
Osada, Takuya, Erika J. Crosby, Kensuke Kaneko, Joshua C. Snyder, Joshua D. Ginzel, Chaitanya R. Acharya, Xiao-Yi Yang, et al. “HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study.” Mol Cancer Ther 21, no. 1 (January 2022): 217–26. https://doi.org/10.1158/1535-7163.MCT-21-0334.
Tan, Wei Phin, Ardeshir R. Rastinehad, Laurence Klotz, Peter R. Carroll, Mark Emberton, John F. Feller, Arvin K. George, et al. “Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus.” Urol Oncol 39, no. 11 (November 2021): 781.e17-781.e24. https://doi.org/10.1016/j.urolonc.2021.01.027.